XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Sale of Future Revenue - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 29 Months Ended
Nov. 03, 2020
Nov. 30, 2020
Dec. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2020
Jun. 30, 2020
Mar. 31, 2023
Disaggregation of Revenue [Line Items]                
Payments for loan acquisition costs       $ 2,909        
Revenues       11,134 $ 12,270      
Royalty                
Disaggregation of Revenue [Line Items]                
Revenues       (27)        
MAM Pangolin Royalty , LLC | Maximum                
Disaggregation of Revenue [Line Items]                
Proceeds from sale of future revenue $ 125,000              
License agreement with Sunovion Pharmaceuticals, Inc.                
Disaggregation of Revenue [Line Items]                
Minimum annual royalty receivable     $ 1,000 $ 1,000   $ 1,000   $ 1,000
License agreement with Sunovion Pharmaceuticals, Inc. | Royalty                
Disaggregation of Revenue [Line Items]                
Revenues           $ 8,000 $ 8,000  
Monetization Agreement                
Disaggregation of Revenue [Line Items]                
Effective annual interest rate 24.90%              
Monetization Agreement | MAM Pangolin Royalty , LLC                
Disaggregation of Revenue [Line Items]                
Proceeds from sale of future revenue $ 40,000   $ 10,000         $ 50,000
Proceeds from debt, contingent on additional milestones $ 75,000 $ 75,000